Photodiagnosis and Photodynamic Therapy
Volume 7, Issue 2 , Pages 129-133 , June 2010

Lacrimal gland mantle lymphoma treated with photodynamic therapy: Overview and report of a case

  • Zaid Hamdoon

      Affiliations

    • UCLH Head and Neck Centre, London, United Kingdom
    • ,
  • Waseem Jerjes

      Affiliations

    • UCLH Head and Neck Centre, London, United Kingdom
    • Unit of Oral and Maxillofacial Surgery, UCL Eastman Dental Institute, London, United Kingdom
    • Department of Surgery, University College London Medical School, London, United Kingdom
    • ,
  • Tahwinder Upile

      Affiliations

    • UCLH Head and Neck Centre, London, United Kingdom
    • Department of Surgery, University College London Medical School, London, United Kingdom
    • Department of Head & Neck Surgery, The Professorial Unit, The Royal National Throat, Nose and Ear Hospital, London, United Kingdom
    • ,
  • Jonas Osher

      Affiliations

    • UCLH Head and Neck Centre, London, United Kingdom
    • ,
  • Colin Hopper, MD, FRCS

      Affiliations

    • UCLH Head and Neck Centre, London, United Kingdom
    • Unit of Oral and Maxillofacial Surgery, UCL Eastman Dental Institute, London, United Kingdom
    • Department of Surgery, University College London Medical School, London, United Kingdom
    • Corresponding Author InformationCorresponding author at: Head & Neck Centre, University College Hospital, 1st Floor East Wing, 250 Euston Road, London NW1 2PG, United Kingdom.

References 

  1. Shivdasani RA, Hess JL, Skarin AT, Pinkus GS. Intermediate lymphocytic lymphoma: clinical and pathological features of a recently characterized subtype of non-Hodgkin's lymphoma. J Clin Oncol. 1993;11:802–811
  2. Lennert K, Stein H, Kaiserling E. Cytological and functional criteria for the classification of malignant lymphomata. Br J Cancer. 1975;31:29–43
  3. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361–1392
  4. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia November, 1997. J Clin Oncol. 2000;18:2788–2789
  5. Anderson JR, Armitage JO, Weisenburger DD for the Non-Hodgkin's Lymphoma Classification Project. Epidemiology of the non-Hodgkin's lymphomas; distributions of the major subtypes differ by geographic locations. Ann Oncol. 1998;9:717–720
  6. Auw-Haedrich C, Coupland SE, Kapp A, et al. Long-term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Br J Ophthalmol. 2001;85:63–69
  7. Looi A, Gascoyne RD, Chhanabhai M, Connors JM, Rootman J, White VA. Mantle cell lymphoma in the ocular adnexal region. Ophthalmology. 2005;112(January (1)):114–119
  8. Isaacson PG, Muller-Hermenlink HK, Piris MA, Harris NL, et al. Extranodal marginal zone B-cell lymphoma of mucoas-associated lymphoid tissue (MALT lymphoma). World Health Organization Classification of Tumors. Lyons, France: IARC Press; 2001;p. 156–161
  9. Fitzpatrick PJ, Macko S. Lymphoreticular tumors of the orbit. Int J Radiat Oncol Biol Phys. 1984;10:333–340
  10. Coupland SE, Hummel M, Stein H. Ocular adnexal lymphomas: five case presentations and a review of the literature. Surv Ophthalmol. 2002;47:470–490
  11. Lenz G, Dreyling M, Hoster E, et al. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). J Clin Oncol. 2005;23:1984–1992
  12. Jindra P, Koza V, Svojgrova M, Skopek P, Vozobulova V, Schützova M. Frontline transplantation of autologous CD34+ selected blood cells for advanced mantle cell lymphoma: no evidence of long-term cure: a single centre experience. Bone Marrow Transplant. 2000;26:1138–1139
  13. Fenske TS, Kahl BS, Eickhoff J, et al. Excessive toxicity of the high dose thiotepa and etoposide regimen when combined with radiation: Long-term autologous transplantation experience in follicular and mantle cell lymphoma. Leuk Lymphoma. 2005;46(October (10)):1441–1448
  14. Martinet S, Ozsahin M, Belkacemi Y, Landmann C, Poortmans P, Oehlere C. Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2003;55:892–898
  15. Bessel EM, Henk JM, Wright JE, Whitelocke RA. Orbital and conjunctival lymphoma: treatment and prognosis. Radither Oncol. 1988;13:237–244
  16. Fingar VH, Wieman TJ, Wiehle SA, Cerrito PB. The role of microvascular damage in photodynamic therapy: the effects of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res. 1992;52:4914–4921
  17. Bolek TW, Moyses HM, Marcus RB, et al. Radiotherapy in the management of orbital lymphoma. Int J Radiat Oncol Biol Phys. 1999;44:31–36
  18. Deahl JT, Oleinick NL, Evans HH. Large mutagenic lesions are induced by photodynamic therapy in murine LS5178Y lymphoblasts. Photochem Photobiol. 1993;58:259–264
  19. Wolf P, Fink-Puches R, Cerroni L, et al. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. J Am Acad Dermatol. 1994;31:678–680
  20. Wang I, Bauer B, Andersson-Engels S, et al. Photodynamic therapy utilising topical delta-aminolevulinic acid in nonmelanoma skin malignancies of the eyelid and the periocular skin. Acta Ophthalmol Scand. 1999;77:182–188

PII: S1572-1000(09)00166-5

doi: 10.1016/j.pdpdt.2009.12.003

Photodiagnosis and Photodynamic Therapy
Volume 7, Issue 2 , Pages 129-133 , June 2010

Article Tools

* Image Usage & Resolution